BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38570226)

  • 21. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.
    Murakami R; Nishimura R; Baba Y; Furusawa M; Ogata N; Yumoto E; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):471-5. PubMed ID: 15667969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of T1b glottic SCC: laser vs. radiation--a Canadian multicenter study.
    Taylor SM; Kerr P; Fung K; Aneeshkumar MK; Wilke D; Jiang Y; Scott J; Phillips J; Hart RD; Trites JR; Rigby MH
    J Otolaryngol Head Neck Surg; 2013 Mar; 42(1):22. PubMed ID: 23672802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
    Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
    Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes.
    Warner L; Lee K; Homer JJ
    Clin Otolaryngol; 2017 Jun; 42(3):629-636. PubMed ID: 27863075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
    Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J
    Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
    Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of pathologically determined tumour volume in glottic carcinomas treated by transoral laser microsurgery.
    Wilkie MD; Lightbody KA; Pinto R; Tandon S; Jones TM; Lancaster J
    Clin Otolaryngol; 2015 Dec; 40(6):610-5. PubMed ID: 25816841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group.
    Lyhne NM; Johansen J; Kristensen CA; Andersen E; Primdahl H; Andersen LJ; Oksbjerg S; Overgaard J
    Eur J Cancer; 2016 May; 59():46-56. PubMed ID: 27014799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].
    Gong H; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Zhou J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):316-320. PubMed ID: 33794628
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathologic Tumor Size as a Predictor of the Survival Outcomes of Patients With Glottic Carcinoma.
    Gong H; Zhou L; Wu H; Tao L; Zhang M; Chen X; Li X; Li C; Zhou J; Wang S
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):353-358. PubMed ID: 32633609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of prognostic nomogram for T1N0M0 glottic squamous cell carcinoma: an SEER database analysis.
    Ming W; Zuo J; Han J; Chen J
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2397-2410. PubMed ID: 36454384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma.
    Pham TA; De Freitas R; Sigston E; Vallance N
    ANZ J Surg; 2012 Oct; 82(10):720-3. PubMed ID: 22901105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T1 squamous cell carcinoma of the glottis with anterior commissure involvement: Radiotherapy versus transoral laser microsurgery.
    Alkan U; Nachalon Y; Shkedy Y; Yaniv D; Shvero J; Popovtzer A
    Head Neck; 2017 Jun; 39(6):1101-1105. PubMed ID: 28371063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone?
    Lee WR; Mancuso AA; Saleh EM; Mendenhall WM; Parsons JT; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):683-7. PubMed ID: 8454487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T1-2 glottic cancer treated with radiotherapy and/or surgery.
    Shelan M; Anschuetz L; Schubert AD; Bojaxhiu B; Dal Pra A; Behrensmeier F; Aebersold DM; Giger R; Elicin O
    Strahlenther Onkol; 2017 Dec; 193(12):995-1004. PubMed ID: 28474090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncological outcomes of early glottic carcinoma treated with transoral robotic surgery.
    Kayhan FT; Koc AK; Erdim I
    Auris Nasus Larynx; 2019 Apr; 46(2):285-293. PubMed ID: 30217617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.